Stocks · News reference

UBS Maintains Sell on Dillard's, Raises Price Target to $468

Aug 17, 2026, 2:20 PMBenzinga Newsdesk

UBS analyst Mauricio Serna maintains Dillard's (NYSE:DDS) with a Sell and raises the price target from $465 to $468.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Globenewswire IncSep 18, 2026, 10:50 AMNa
Dillard’s, Inc. to Transfer U.S. Stock Exchange Listings to the Texas Stock Exchange (TXSE)
Dillard's, Inc. announced it will voluntarily transfer the primary listings of its Class A Common Stock (DDS) and Capital Securities (DDT) from the New York Stock Exchange to the Texas Stock Exchange, effective October 5, 2026. The move aligns the company's Texas heritage and largest market presence with TXSE's technology-driven platform. Dillard's reincorporated from Delaware to Texas in August 2025.
DDS DDT
BenzingaSep 18, 2026, 10:53 AMBenzinga Newsdesk
Dillard’s To Voluntarily Transfer Its Primary Listings From The NYSE To The Texas Stock Exchange
The transfer applies to both Dillard’s Class A Common Stock (ticker: DDS) and the 7.50% Capital Securities of Dillard’s Capital Trust I (and the Guarantee of the Company with respect thereto) (ticker: DDT). Both
DDS
BenzingaAug 17, 2026, 3:23 PMBenzinga Newsdesk
JP Morgan Maintains Underweight on Dillard's, Raises Price Target to $519
JP Morgan analyst Matthew Boss maintains Dillard's (NYSE:DDS) with a Underweight and raises the price target from $496 to $519.
DDS